S.298 - A bill to amend title 35, United States Code, with respect to patents on certain processes.103rd Congress (1993-1994)
|Sponsor:||Sen. DeConcini, Dennis [D-AZ] (Introduced 02/03/1993)|
|Committees:||Senate - Judiciary | House - Judiciary|
|Committee Reports:||S.Rept 103-82|
|Latest Action:||House - 08/09/1994 Referred to the Subcommittee on Intellectual Property and Judicial Administration. (All Actions)|
This bill has the status Passed Senate
Here are the steps for Status of Legislation:
- Passed Senate
Summary: S.298 — 103rd Congress (1993-1994)All Information (Except Text)
Introduced in Senate (02/03/1993)
TABLE OF CONTENTS:
Title I: Biotechnological Process Patents
Title II: Biotechnological Material Patents
Title I: Biotechnological Process Patents - Amends Federal patent law to cite conditions under which a claimed process of making or using a machine, manufacture, or composition of matter is not obvious (thereby enhancing the patentability prospects of certain biotechnology processes). Establishes a presumption of validity with respect to a process claim even through a related product claim is invalidated (thus allowing a patentee to prove that the process claim is independently patentable from the product claim).
Title II: Biotechnological Material Patents - Makes any unauthorized person who imports or sells a product made by using a biotechnological material that is patented in the United States liable for patent infringement. Includes within the terms of such patents the right to exclude others from using, selling, or importing such products throughout or into the United States. Establishes exceptions to such requirements to the extent suitable to protect commercial investment made or business commenced before the effective date of such amendments.